Navigation Links
Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) congratulates Mario R. Capecchi today for the richly deserved honor of the 2007 Nobel Prize in Physiology or Medicine. Capecchi, who sits on FBR's Board of Governors, is currently a Distinguished Professor and Co-Chair of the Human Genetics Department at the University of Utah, School of Medicine.

"Groundbreaking research such as Dr. Capecchi's has enabled the study of diseases in a way never before thought possible," said FBR President Frankie L. Trull. "This further demonstrates the incredible power and promise of the humane use of animal models in medical research."

The Nobel Foundation recognized Capecchi and two other researchers for the discovery of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." Their studies resulted in genetically altered mouse models, innovating the way researchers work to combat such diseases as cancer, diabetes and Alzheimer's.

Capecchi's Nobel Prize-winning work involved gene targeting in mouse embryonic stem cells, allowing scientists to study the pathology of disease in a living system whose genes have been either inactivated or modified. Scientists can now target specific disease-causing genes in an effort to discover new cures or treatments that afflict both humans and animals.

Upon joining FBR's Board of Governors, Capecchi said, "I am a very strong advocate for the respect and support of animal research. My scientific life has been devoted to the use of mouse models for the understanding of the development of therapies of human disease as well as for the pathologies."

FBR's Board of Governors now includes ten Nobel Laureates. Capecchi is a recipient of numerous other awards, including the Albert Lasker Award in 2001.

FBR is the nation's foremost organization devoted to promoting public understanding, respect, and support for the humane and responsible use of animals in medical and scientific research. For more information on FBR, please visit its Web site at http://www.fbresearch.org.


'/>"/>
SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
5. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
6. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
7. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
10. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... , May 24, 2016 ... the world , s first dual ... fistula intervention   OrbusNeich, a global company ... expanded its portfolio to include products to treat peripheral ... the company,s first entry devices for lower limb and ...
(Date:5/24/2016)... , May 24, 2016 Dutch surgeons have ... practices around the world and treat patients on a global scale. ... , Asia and the US have ... instant messaging and networking in a totally secure environment. ... a war zone working together with a surgeon at Harvard to ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... ... North Cypress Medical Center hosted its 9th Annual Spring Classic ... help of community partners, the event organizers raised $45,000 for the Lone Survivor ... and their families through health, wellness, and therapeutic support. , A special military ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... ... ... The introduction of our professional athletes coincides with the company’s new campaign: “LOOK ... are proud to introduce Meghan Klingenberg, defender and World Champion with the US Women’s ... Los Angeles who was a second round selection in the 2012 NFL draft. We ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. LeRoy Perry’s recently authored whitepaper, ... mobile devices on the billions of users, hundreds of millions of whom are coming ... life threatening, the frequent and common action of looking down at hand-held technology devices ...
(Date:5/26/2016)... ... May 26, 2016 , ... In Madeira Beach Florida, a small town ... drawbridge, citizens formed an organization, Madeira Beach United, to oppose two development projects undertaken ... town center to a high rise urban environment. , According to the Tampa ...
Breaking Medicine News(10 mins):